Literature DB >> 11819867

Management of patients with a short bowel.

J M Nightingale1.   

Abstract

There are two common types of adult patient with a short bowel, those with jejunum in continuity with a functioning colon and those with a jejunostomy. Both groups have potential problems of undernutrition, but this is a greater problem in those without a colon, as they do not derive energy from anaerobic bacterial fermentation of carbohydrate to short chain fatty acids in the colon. Patients with a jejunostomy have major problems of dehydration, sodium and magnesium depletion all due to a large volume of stomal output. Both types of patient have lost at least 60 cm of terminal ileum and so will become deficient of vitamin B(12). Both groups have a high prevalence of gallstones (45%) resulting from periods of biliary stasis. Patients with a retained colon have a 25% chance of developing calcium oxalate renal stones and they may have problems with D(-) lactic acidosis. The survival of patients with a short bowel, even if they need long-term parenteral nutrition, is good.

Entities:  

Mesh:

Year:  2001        PMID: 11819867      PMCID: PMC4695587          DOI: 10.3748/wjg.v7.i6.741

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  207 in total

Review 1.  Treatment of enteric hyperoxaluria.

Authors:  J Harper; M A Mansell
Journal:  Postgrad Med J       Date:  1991-03       Impact factor: 2.401

2.  Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride.

Authors:  A F Hofmann; J R Poley
Journal:  Gastroenterology       Date:  1972-05       Impact factor: 22.682

3.  Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome.

Authors:  B Messing; P Crenn; P Beau; M C Boutron-Ruault; J C Rambaud; C Matuchansky
Journal:  Gastroenterology       Date:  1999-11       Impact factor: 22.682

4.  Effect of codeine and loperamide on upper intestinal transit and absorption in normal subjects and patients with postvagotomy diarrhoea.

Authors:  J D O'Brien; D G Thompson; A McIntyre; W R Burnham; E Walker
Journal:  Gut       Date:  1988-03       Impact factor: 23.059

5.  Behavior of various cholesterol crystals in bile from patients with gallstones.

Authors:  P Portincasa; K J van Erpecum; A Jansen; W Renooij; M Gadellaa; G P vanBerge-Henegouwen
Journal:  Hepatology       Date:  1996-04       Impact factor: 17.425

6.  The metabolism of [75Se]selenite in patients with short bowel syndrome.

Authors:  T Rannem; E Hylander; K Ladefoged; M Staun; L Tjellesen; S Jarnum
Journal:  JPEN J Parenter Enteral Nutr       Date:  1996 Nov-Dec       Impact factor: 4.016

7.  Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome.

Authors:  K Ladefoged; K C Christensen; J Hegnhøj; S Jarnum
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

8.  Intestinal excretion of oxalate in chronic renal failure.

Authors:  M Hatch; R W Freel; N D Vaziri
Journal:  J Am Soc Nephrol       Date:  1994-12       Impact factor: 10.121

9.  Octreotide and postoperative enterocutaneous fistulae: a controlled prospective study.

Authors:  N A Scott; S Finnegan; M H Irving
Journal:  Acta Gastroenterol Belg       Date:  1993 May-Aug       Impact factor: 1.316

10.  Low-oxalate, low-fat dietary regimen in hyperoxaluria following jejunoileal bypass.

Authors:  B Nordenvall; L Backman; P Burman; L Larsson; H G Tiselius
Journal:  Acta Chir Scand       Date:  1983
View more
  12 in total

1.  Changes induced in colonocytes by extensive intestinal resection in rats.

Authors:  Hubert Lardy; Muriel Thomas; Marie-Louise Noordine; Aurélia Bruneau; Claire Cherbuy; Pierre Vaugelade; Catherine Philippe; Virginie Colomb; Pierre-Henri Duee
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

Review 2.  Magnesium disorders can cause calcium pyrophosphate deposition disease: A case report and literature review.

Authors:  Akanksha Joshi; Chokkalingam Siva
Journal:  Eur J Rheumatol       Date:  2017-08-29

Review 3.  Management and Complications of Short Bowel Syndrome: an Updated Review.

Authors:  Robert E Carroll; Enrico Benedetti; Joseph P Schowalter; Alan L Buchman
Journal:  Curr Gastroenterol Rep       Date:  2016-07

Review 4.  The value of multidisciplinary nutritional gastroenterology clinics for intestinal failure and other gastrointestinal patients.

Authors:  Ajay Kiran Muddu; Michael A Stroud
Journal:  Frontline Gastroenterol       Date:  2010-09-23

5.  Chronic cholestasis in patients on parenteral nutrition: the influence of restoring bowel continuity after mesenteric infarction.

Authors:  F Adaba; M Uppara; F Iqbal; S Mallappa; C J Vaizey; S M Gabe; J Warusavitarne; J M D Nightingale
Journal:  Eur J Clin Nutr       Date:  2015-09-09       Impact factor: 4.016

6.  Ileostomy diarrhea.

Authors:  Andrew W DuPont; Joseph H Sellin
Journal:  Curr Treat Options Gastroenterol       Date:  2006-02

7.  Hypokalaemic Periodic Paralysis- A Prospective Study of the Underlying Etiologies.

Authors:  Surya Narayana Jandhyala; Jagadesh Madireddi; Jayaprakash Belle; N R Rau; Ranjan Shetty
Journal:  J Clin Diagn Res       Date:  2015-09-01

8.  Chronic calcium pyrophosphate crystal inflammatory arthritis induced by extreme hypomagnesemia in short bowel syndrome.

Authors:  Markus Hahn; Martin Raithel; Alexander Hagel; Teresa Biermann; Bernhard Manger
Journal:  BMC Gastroenterol       Date:  2012-09-22       Impact factor: 3.067

Review 9.  Current treatment paradigms in pediatric short bowel syndrome.

Authors:  Raghav Chandra; Anil Kesavan
Journal:  Clin J Gastroenterol       Date:  2017-12-26

10.  Oral Cobalamin Supplementation in Dogs with Chronic Enteropathies and Hypocobalaminemia.

Authors:  L Toresson; J M Steiner; J S Suchodolski; T Spillmann
Journal:  J Vet Intern Med       Date:  2015-12-09       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.